| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3538563 | A | Drug metabolism in human liver cytosol assessed as (1R,2S,5S)-N-((2R,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide formation after 60 mins by LC-MS/MS/FSA method | Homo sapiens | 2 | ALA3526141 | tissue-based format | Scientific Literature | |
| 2. | ALA3538564 | A | Drug metabolism in human liver cytosol assessed as (1R,2S,5S)-N-((2R,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide formation per mg protein after 60 mins by LC-MS/MS/FSA method | Homo sapiens | 2 | ALA3526141 | tissue-based format | Scientific Literature | |
| 3. | ALA3538565 | A | Ratio of Vmax to Km for drug metabolism in human liver cytosol assessed as (1R,2S,5S)-N-((2R,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide formation per mg protein after 60 mins by LC-MS/MS/FSA method | Homo sapiens | 2 | ALA3526141 | assay format | Scientific Literature | |
| 4. | ALA3538859 | A | Drug metabolism in human liver cytosol at 20 uM assessed as (1R,2S,5S)-N-((2R,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide formation in presence of flufenamic acid by LC-MS/MS/FSA method | Homo sapiens | 1 | ALA3526141 | assay format | Scientific Literature | |
| 5. | ALA3538860 | A | Drug metabolism in human liver cytosol at 20 uM assessed as (1R,2S,5S)-N-((2R,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide formation at 20 uM after 60 mins in presence of AKR inhibitor diazepam by LC-MS/MS/FSA method | Homo sapiens | 1 | ALA3526141 | assay format | Scientific Literature | |
| 6. | ALA3538861 | A | Drug metabolism in human liver cytosol at 20 uM assessed as (1R,2S,5S)-N-((2R,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide formation at 20 uM after 60 mins in presence of AKR inhibitor ibuprofen by LC-MS/MS/FSA method | Homo sapiens | 1 | ALA3526141 | assay format | Scientific Literature | |
| 7. | ALA3538862 | A | Drug metabolism in human liver cytosol at 20 uM assessed as (1R,2S,5S)-N-((2R,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide formation in presence of BNPP by LC-MS/MS/FSA method | Homo sapiens | 1 | ALA3526141 | assay format | Scientific Literature | |
| 8. | ALA3541797 | A | Drug metabolism in human liver cytosol at 20 uM assessed as (1R,2S,5S)-N-((2S,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide formation in presence of BNPP by LC-MS/MS/FSA method | Homo sapiens | 1 | ALA3526141 | assay format | Scientific Literature | |
| 9. | ALA3539294 | P | Retention time of the compound by LC-MS/MS method | 23 | ALA3526141 | small-molecule physicochemical format | Scientific Literature | ||
| 10. | ALA3539295 | A | Drug metabolism in human plasma treated with [14C]boceprevir assessed as ratio of drug level by LC-MS/MS method relative to boceprevir | Homo sapiens | 23 | ALA3526141 | cell-free format | Scientific Literature | |
| 11. | ALA3539296 | A | Drug metabolism in human liver microsomes treated with 5 uM [14C]boceprevir assessed as compound formation by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 20 | ALA3526141 | assay format | Scientific Literature | |
| 12. | ALA3539297 | A | Drug metabolism in human liver microsomes treated with 20 uM [14C]boceprevir assessed as compound formation by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 21 | ALA3526141 | assay format | Scientific Literature | |
| 13. | ALA3539298 | A | Drug metabolism assessed as human CYP3A4-mediated compound formation from 5 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 21 | ALA3526141 | single protein format | Scientific Literature | |
| 14. | ALA3539299 | A | Drug metabolism assessed as human CYP3A4-mediated compound formation from 20 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 22 | ALA3526141 | single protein format | Scientific Literature | |
| 15. | ALA3539300 | A | Drug metabolism assessed as human CYP3A5-mediated compound formation from 5 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 21 | ALA3526141 | single protein format | Scientific Literature | |
| 16. | ALA3539301 | A | Drug metabolism assessed as human CYP3A5-mediated compound formation from 20 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 22 | ALA3526141 | single protein format | Scientific Literature | |
| 17. | ALA3539302 | A | Drug metabolism assessed as human CYP2D6-mediated compound formation from 5 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 21 | ALA3526141 | single protein format | Scientific Literature | |
| 18. | ALA3539303 | A | Drug metabolism assessed as human CYP2C19-mediated compound formation from 5 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 21 | ALA3526141 | single protein format | Scientific Literature | |
| 19. | ALA3539304 | A | Drug metabolism assessed as human CYP21A2-mediated compound formation from 5 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 22 | ALA3526141 | single protein format | Scientific Literature | |
| 20. | ALA3539305 | A | Drug metabolism assessed as human CYP21A1-mediated compound formation from 5 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir | Homo sapiens | 22 | ALA3526141 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!